Orlistat improves endothelial function in obese adolescents: a randomised trial.

Area of Science:

• Pediatric Endocrinology
• Cardiovascular Health
• Pharmacology

Background:

• Obesity in adolescents is a growing concern linked to poor endothelial function and increased cardiovascular risk.
• Lifestyle interventions are crucial, but pharmacological support may offer additional benefits.

Purpose of the Study:

• To evaluate the impact of orlistat on endothelial function in obese adolescents.
• To assess changes in anthropometric and metabolic parameters with orlistat treatment.

Main Methods:

• A 10-week, single-blind, controlled trial involving 67 obese adolescents.
• Participants were randomized into diet alone, diet plus orlistat, or diet, orlistat, and exercise groups.
• Endothelial function was assessed via flow-mediated dilatation (FMD), with other parameters measured at baseline and 10 weeks.

Main Results:

• Orlistat significantly improved FMD in obese adolescents.
• Treatment led to reductions in body weight, BMI, waist circumference, and LDL cholesterol.
• While triglycerides and insulin decreased across all groups, orlistat specifically impacted calorie and macronutrient intake.

Conclusions:

• Orlistat, when combined with dietary management, enhances endothelial function in obese adolescents.
• These findings suggest that orlistat may offer long-term cardiovascular protection in this population.